Get 20% lifetime commission for referring investors to digrin.com
here.
BioInvent International AB (publ) ( BOVNF) - Key Metrics
BOVNF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.19 | -$1.85 | -$1.69 | -$1.70 |
| 2026Q1 | $0.20 | -$1.81 | -$2.02 | -$2.03 |
| 2025Q4 | $0.05 | -$1.92 | -$1.37 | -$1.39 |
| 2025Q3 | $0.05 | -$1.95 | -$1.57 | -$1.60 |
| 2025Q2 | $3.01 | $0.59 | $0.11 | $0.99 |
BOVNF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.36 |
| 2026Q1 | 0% | -4.29 |
| 2025Q4 | 0% | -3.95 |
| 2025Q3 | 0% | -3.93 |
| 2025Q2 | 0% | 13.15 |
BOVNF
Price: $3.29
52 week price:
Earnings Per Share: -0.47 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 216.4 million